Studies have found that the overexpression of VISTA on tumor cells in murine cancer models can trigger the immune protection of tumor cell growth, and the application of VISTA monoclonal antibody treatment can control tumor growth, and the combined use of tumor vaccines will produce significant results [16]. This evidence concerns the gene VSIR and neoplasm.